Skip to main
LFST

LFST Stock Forecast & Price Target

LFST Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 43%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

LifeStance Health Gr is a rapidly-growing mental health services provider with effective treatment options for a range of conditions. Despite competition and potential challenges, the company's focus on quality care and utilization of technology make it well-positioned for continued success. With strong partnerships and an experienced team, LifeStance is poised to maintain a significant presence in the mental health industry.

Bears say

LifeStance Health Gr is a mental healthcare company that has a single operating segment and provides outpatient mental health services. Key risks include competition from other health-tech companies, potential cybersecurity threats and data breaches, and exposure to reimbursement rates for mental health services. The recent change in the incentive compensation structure for clinicians and partnership with "Calm" could be positive drivers, but the company still faces uncertainties due to market demand and economic conditions. Financially, LFST's valuation at EV / 10.9x 2027E EBITDA appears high compared to its peers.

LFST has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 43% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of LifeStance Health Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About LifeStance Health Group (LFST) Forecast

Analysts have given LFST a Buy based on their latest research and market trends.

According to 7 analysts, LFST has a Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

LifeStance Health Group (LFST)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.